+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cough Suppressant Drugs Market by Product Form (Capsule, Drop, Lozenge), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Prescription Status, Active Ingredient, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989771
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cough Suppressant Drugs Market is adapting to a complex landscape shaped by evolving patient expectations, regulatory realignment, and emerging supply chain challenges. Industry leaders in this space are tasked with navigating advances in formulation, shifting consumer preferences, and compliance dynamics to secure sustained success.

Market Snapshot: Cough Suppressant Drugs Market Growth and Trends

The cough suppressant drugs market grew from USD 2.07 billion in 2024 to USD 2.17 billion in 2025. It is expected to continue growing at a CAGR of 4.65%, reaching USD 2.72 billion by 2030. This upward trend reflects not only rising global respiratory disease prevalence, but also increased demand for diversified, patient-centric formulations and increased investments in digital health initiatives. Market performance is further enhanced by global regulatory harmonization and active innovation in drug delivery technologies.

Cough Suppressant Drugs Market: Scope & Segmentation

The report delivers comprehensive market insights, spanning product innovation, distribution evolution, and geographical expansion. Segmentation reflects current and emerging priorities for senior stakeholders:

  • Product Forms: Capsule (hard, soft gelatin), drop, lozenge (flavored, unflavored), traditional and sugar-free syrups, chewable, conventional, and orally disintegrating tablets.
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies.
  • Prescription Status: Over the counter, prescription only.
  • Active Ingredients: Benzonatate, codeine, dextromethorphan, diphenhydramine, guaifenesin, herbal extracts (eucalyptus oil, honey, thyme extract).
  • End Users: Ambulatory centers, clinics, homecare, hospitals.
  • Regions: Americas (including major US states, Canada, Mexico, Brazil, Argentina), Europe-Middle East-Africa (key EU states, GCC countries, and Africa), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia).
  • Key Companies Covered: Kenvue Inc., Haleon plc, Reckitt Benckiser Group plc, Sanofi S.A., Bayer AG, Boehringer Ingelheim, Novartis AG, Teva, Perrigo Company plc, Viatris Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • The evolution of cough suppressant medications is characterized by diversification from traditional syrups to innovative delivery systems, meeting the demands of diabetic, pediatric, and health-conscious consumers.
  • Adoption of microencapsulation and targeted drug release matrices is increasing efficiency, improving patient adherence, and enabling integration with digital health platforms.
  • Growing demand for herbal and clean-label formulations is driving reformulation, with manufacturers balancing stability and therapeutic efficacy for wellness-driven segments.
  • Major players are leveraging R&D and manufacturing innovation, and using digital tools to align formulation, compliance, and channel engagement strategies.
  • Regional market entry requires targeted adaptations, reflecting variable regulatory environments, consumer preferences, and distribution capabilities in North America, EMEA, and Asia-Pacific.

Cough Suppressant Drugs Market Tariff Impact

The 2025 United States tariff adjustments have significantly altered cough suppressant drug supply chains. Active pharmaceutical ingredients face new duties, motivating manufacturers to seek tariff-exempt sourcing and renegotiate supplier contracts. Companies are adapting logistics, including use of free trade zones and bonded warehousing, to protect margins and increase agility. This environment highlights the strategic importance of supply chain resilience and proactive tariff management in global operations.

Methodology & Data Sources

This report uses a blended methodology. Primary interviews with executives in manufacturing, supply chain, regulatory affairs, and healthcare distribution complement secondary reviews from peer-reviewed journals, regulatory filings, and proprietary market databases. Qualitative and quantitative analyses validate trends and assess segment performance.

Why This Report Matters

  • Empowers senior stakeholders to anticipate regulatory, supply chain, and technology shifts, reducing risk in strategy design.
  • Provides an actionable framework for identifying and prioritizing high-growth regions, product forms, and distribution channels.
  • Delivers insights into operational best practices underpinned by real-world data and cross-functional industry expertise.

Conclusion

This report equips decision-makers with a focused, actionable view of the cough suppressant drugs market. It balances innovation dynamics, operational resilience, and consumer trends to support long-term competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of dextromethorphan-based lozenges with enhanced bioavailability through nanoemulsion technology
5.2. Surge in pediatric cough suppressant syrups formulated with natural honey extracts and reduced sugar content
5.3. Increasing investment in extended-release caplets delivering 24-hour cough relief without sedative effects
5.4. Emergence of OTC cough drops infused with cannabidiol to capitalize on holistic wellness and anti-inflammatory claims
5.5. Rising strategic partnerships between pharmaceutical giants and biotech startups for opioid-free antitussive drug development
5.6. Integration of smart packaging with dosage tracking features to improve patient adherence and reduce overconsumption
5.7. Expansion of e-commerce channels and telemedicine platforms for direct-to-consumer cough suppressant distribution
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cough Suppressant Drugs Market, by Product Form
8.1. Introduction
8.2. Capsule
8.2.1. Hard Capsule
8.2.2. Soft Gelatin Capsule
8.3. Drop
8.4. Lozenge
8.4.1. Flavored
8.4.2. Unflavored
8.5. Syrup
8.5.1. Sugar-Based
8.5.2. Sugar-Free
8.6. Tablet
8.6.1. Chewable Tablet
8.6.2. Conventional Tablet
8.6.3. Orally Disintegrating Tablet
9. Cough Suppressant Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Cough Suppressant Drugs Market, by Prescription Status
10.1. Introduction
10.2. Over The Counter
10.3. Prescription
11. Cough Suppressant Drugs Market, by Active Ingredient
11.1. Introduction
11.2. Benzonatate
11.3. Codeine
11.4. Dextromethorphan
11.5. Diphenhydramine
11.6. Guaifenesin
11.7. Herbal Extracts
11.7.1. Eucalyptus Oil
11.7.2. Honey
11.7.3. Thyme Extract
12. Cough Suppressant Drugs Market, by End User
12.1. Introduction
12.2. Ambulatory Center
12.3. Clinic
12.4. Homecare
12.5. Hospital
13. Americas Cough Suppressant Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cough Suppressant Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cough Suppressant Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Kenvue Inc.
16.3.2. Haleon plc
16.3.3. Reckitt Benckiser Group plc
16.3.4. Sanofi S.A.
16.3.5. Bayer Aktiengesellschaft
16.3.6. Boehringer Ingelheim International GmbH
16.3.7. Novartis AG
16.3.8. Teva Pharmaceutical Industries Ltd.
16.3.9. Perrigo Company plc
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. COUGH SUPPRESSANT DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COUGH SUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. COUGH SUPPRESSANT DRUGS MARKET: RESEARCHAI
FIGURE 26. COUGH SUPPRESSANT DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. COUGH SUPPRESSANT DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. COUGH SUPPRESSANT DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COUGH SUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HARD CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOFT GELATIN CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOFT GELATIN CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DROP, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DROP, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FLAVORED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FLAVORED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY UNFLAVORED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY UNFLAVORED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-FREE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUGAR-FREE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CHEWABLE TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CHEWABLE TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CONVENTIONAL TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CONVENTIONAL TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ORALLY DISINTEGRATING TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ORALLY DISINTEGRATING TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DIPHENHYDRAMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DIPHENHYDRAMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GUAIFENESIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GUAIFENESIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY EUCALYPTUS OIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY EUCALYPTUS OIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HONEY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HONEY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY THYME EXTRACT, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY THYME EXTRACT, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AMBULATORY CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AMBULATORY CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 138. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 139. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 140. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 141. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 142. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 143. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 144. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 145. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 146. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 147. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 150. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 151. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 152. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 153. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 154. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 155. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 158. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 159. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 164. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 165. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 166. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 167. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 172. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 173. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 260. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 261. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 262. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 263. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 264. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 265. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 266. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 267. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 268. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 269. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 274. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 275. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 280. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 281. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 282. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 283. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 284. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 285. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 286. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 287. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 288. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 289. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 292. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 294. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 295. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 296. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 297. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL EXTRACTS, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 320. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 321. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 322. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 323. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2018-2024 (USD MILLION)
TABLE 324. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGE, 2025-2030 (USD MILLION)
TABLE 325. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2024 (USD MILLION)
TABLE 326. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2025-2030 (USD MILLION)
TABLE 327. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 328. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 329. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DIS

Samples

Loading
LOADING...

Companies Mentioned

  • Kenvue Inc.
  • Haleon plc
  • Reckitt Benckiser Group plc
  • Sanofi S.A.
  • Bayer Aktiengesellschaft
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Viatris Inc.

Table Information